Lower prevalence of hypertension, hypercholesterolemia, and diabetes in marathoners

Medicine and Science in Sports and Exercise

Volumn 41, Issue 3, 2009, Pages 523-529

  Williams, Paul T ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Body mass index; Exercise; Metabolic syndrome; Prevention; Running

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MARATHON RUNNER; PREVALENCE; RUNNING; SELF REPORT; STRUCTURED QUESTIONNAIRE; CROSS-SECTIONAL STUDY; DRUG UTILIZATION; MIDDLE AGED; SEX DIFFERENCE; STATISTICS; UNITED STATES;

ADULT; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DRUG UTILIZATION; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; RUNNING; SEX FACTORS; UNITED STATES;

EID: 66149110438     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e31818c1752     Document Type: Article

References (40)

1. Balke B, Ware RW. An experimental study of physical fitness of Air Force personnel. U S Armed Forces Med J. 1959;10:875-88.
2. Bergström J, Hermansen L, Hultman E, Saltin B. Diet, muscle glycogen and physical performance. Acta Physiol Scand. 1967;71:140-50.
3. 2max in the sedentary state: the HERITAGE Family Study. Med Sci Sports Exerc. 1998;30(2):252-8.
4. Boushel R, Gnaiger E, Schjerling P, Skovbro M, KraunsLe R, Della F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia. 2007;50:790-6.
5. Colditz G, Martin AP, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894-900.
6. Cooper KH. A means of assessing maximal oxygen intake: correlation between field and treadmill testing. JAMA. 1968;203:201-4.
7. Coyle EF. Physiological regulation of marathon performance. Sports Med. 2007;37:306-11.
8. Fagard R, Bielen RE, Amery A. Heritability of aerobic power and anaerobic energy generation during exercise. J Appl Physiol. 1991;70:357-62.
9. Foster C, Lucia A. Running economy: the forgotten factor in elite performance. Sports Med. 2007;37:316-9.
10. Hamdy O, Goodyear LJ, Horton ES. Diet and exercise in type 2 diabetes mellitus. Endocrinol Metab Clin North Am. 2001;30:883-907.
11. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39(8):1423-34.
12. Hellerstein HK. Limitations of marathon running in the rehabilitation of coronary patients: anatomic and physiologic determinants. Ann N Y Acad Sci. 1977;301:484-94.
13. Hood DA, Irrcher I, Ljubicic V, Joseph AM. Coordination of metabolic plasticity in skeletal muscle. J Exp Biol. 2006;209:2265-75.
14. Leal-Cerro A, Garcia-Luna PP, Astorga R, et al. Serum leptin levels in male marathon athletes before and after the marathon run. J Clin Endocrinol Metab. 1998;83:2376-9.
15. Leitzmann MF, Giovannucci EL, Rimm EB, et al. The relation of physical activity to risk for symptomatic gallstone disease in men. Ann Intern Med. 1998;128:417-25.
16. Leitzmann MF, Rimm EB, Willett WC et al. Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med. 1999;341:777-84.
17. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307:384-7.
18. Maron BJ. Sudden death in young athletes. N Engl J Med. 2003;349:1064-75.
19. Maron BJ, Araujo CG, Thompson PD, et al. Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes. Circulation. 2001;103:327-34.
20. Noakes TD. Heart disease in marathon runners: a review. Med Sci Sports Exerc. 1987;19(3):187-94.
21. Redelmeier DA, Greenwald JA. Competing risks of mortality with marathons: retrospective analysis. BMJ. 2007;22;335:1275-7.
22. Schmitz-Peiffer C. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal. 2000;12:583-94.
23. Spargo FJ, McGee SL, Dzamko N, et al. Dysregulation of muscle lipid metabolism in rats selectively bred for low aerobic running capacity. Am J Physiol Endocrinol Metab. 2007;292:E1631-6.
24. Spriet LL. Regulation of substrate use during the marathon. Sports Med. 2007;37:332-6.
25. Sundet JM, Magnus P, Tambs K. The heritability of maximal aerobic power: a study of Norwegian twins. Scand J Med Sci Sports. 1994;4:181-5.
26. Taylor AW, Bachman L. The effects of endurance training on muscle fibre types and enzyme activities. Can J Appl Physiol. 1999;24:41-53.
27. Trappe S, Harber M, Creer A, et al. Single muscle fiber adaptations with marathon training. J Appl Physiol. 2006;101:721-7.
28. Web Marketing Associates. 2007 USA Marathon Report. Available from: http://www.marathonguide.com/features/Articles/2007RecapOverview.cfm.
29. Williams PT. High density lipoprotein cholesterol and other risk factors for coronary heart disease in female runners. New Engl J Med. 1996;334:1298-303.
30. Williams PT. Relationship of distance run per week to coronary heart disease risk factors in 9,920 male runners. The National Runners' Health Study. Arch Inter Med. 1997;157:191-8.
31. Williams PT. Exercise and the population distribution of body weight. Int J Obes. 2004;28120-8.
32. Williams PT. Maintaining vigorous activity attenuates 7-yr weight gain in 8340 runners. Med Sci Sports Exer. 2007;39(5):801-9.
33. Williams PT. Self-selection accounts for inverse association between weight and cardiorespiratory fitness. Obesity (Silver Spring). 2008;16:102-6.
34. Williams PT. Vigorous exercise, fitness, and incident hypertension, high cholesterol, and diabetes. Med Sci Sports Exerc. 2008;40(6):998-1006.
35. Williams PT. Reduced diabetic, hypertensive, and cholesterol medication use with walking. Med Sci Sports Exerc. 2008;40(3):433-43.
36. Williams PT. Asymmetric weight gain and loss from increasing and decreasing exercise. Med Sci Sports Exerc. 2008;40(2):296-302.
37. Williams PT, Franklin B. Vigorous exercise and diabetic, hypertensive, and hypercholesterolemia medication use. Med Sci Sports Exerc. 2007;39(11):1933-41.
38. Williams PT, Hoffman K, La I. Weight-related increases in hypertension, hypercholesterolemia, and diabetes risk in normal weight male and female runners. Arterioscler Thromb Vasc Biol. 2007;27:1811-9.
39. WislLff U, Najjar SM, Ellingsen O, et al. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science. 2005;307:418-20.
40. Yeung SS, Yeung EW, Wong TW. Marathon finishers and non-finishers characteristics. A preamble to success. J Sports Med Phys Fitness. 2001;41:170-6.